This report was recently updated on May 23 2023 with the latest and most recent
market numbers
Global Risk-Based Monitoring Software Market Size, Trends, and Analysis- Forecasts To 2026 By Type (Enterprise RMB Software, Site RBM Software), By Component (Software, Services), By Delivery Mode (Web-Based, Licensed Enterprise, Cloud-Based), By End User (Medical Device Companies, Contract Research Organization, Pharmaceutical & Biopharmaceutical Companies), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
The risk-based monitoring software enables the clinical teams to have access to the actionable data sets that improve the clinical programs and trials. The importance of reviewing clinical trials are mandated by the government and certain regulatory authorities to ensure no error and faults. The discovery of new diseases and the rising number of clinical trials and studies indicate a higher trajectory growth for the market evaluation. Also, the growing number of drug therapies in the clinical trial phase and the persistent need for regulatory approval for drug development further accentuates the importance of the software in assessing the risk of clinical trials.The considerable rising number of public and private investment in clinical trials indirectly lead to higher market demand in the aforementioned period. The deployment of risk-based monitoring software enables fewer errors, improved analysis, timely results, and lower cost.
Based on the type, the market studies site RMB software and enterprise RMB software. The enterprise RBM software will hold the largest market share owing to the rising market popularity in Asian countries. The need for large-scale contract organizationsandacademic institutes would help accelerate the market demand in the aforementioned period.
Software and service are the major components of this market. The software division would have a large impact on market growth. The purpose of the software is to have a greater inclination towards more efficient clinical trial analysis. The JMP Clinical works to provide industry-based software tools through intuitive visualization and reliable statistics.
Based on the delivery mode, the market considers cloud-based, licensed enterprise,and web-based into being. The web-based software division will hold a larger market share owing to the varied benefits offered by the web-based software. With web-based software, there is easy accessibility to the business data, increased data software,and improved software maintenance.
Based on end-user, the market is considered intoCROs, medical device companies, and pharma & biotech firms.The pharma & biotech firmsare expected to be the fastest-growing segment in the market. The rising novel drug discovery projects in Europe, the USA, andthe fast deployment of the software inpharmaceutical clinical research would help the segment to grow in the market space. Increasing Engagement of the FDA in the integration of software for clinical trial analysis is also leading to high market demand. The risk assessment helps in the improvement of data quality and also leads to a reduction in clinical costs.
Based on the regional study, the market studies North America to be a key player in the market but the Asia Pacific will emerge as a prominent leader in the forecast period.The booming SaaS market in China’s region and increased focus of pharma companies towards the risk-based monitoring software would help in the high growth of the market in the region.
Key players operating in the market include eClinical, Quanticate, JMPClinical, Clue Points, MasterControl, IBM Corporation, Anju Software, Bioclinica, and DATATRACK among others.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Risk-Based Monitoring Software Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Risk-Based Monitoring Software Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
A dedicated client engagement team for round the clock support in terms of requirement gathering, query handling, and any other support activity.
More than 50% of innovation comes from the voice of the customer through which our analysts find blindspots in your revenue decisions.
The best vision is actionable insights across high growth markets with GMEs disruptive research methodology.
Disruptive research that correlates markets, technologies, new use cases and companies.
80% of Fortune 2000 use GME for their growth strategies.
Get in-depth analysis of the COVID-19 impact on this study
Benchmarking the rapid strategy shifts of the Top 100 companies in this market space
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
